TrialThe oncologist2012

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

Isabelle Ray-Coquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.